BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18277618)

  • 1. Preparation of micro-fabricated biodegradable polymeric structures using NCDS.
    Lee JH; Ha WS; Chu WS; Park CW; Ahn SH; Chi SC
    Arch Pharm Res; 2008 Jan; 31(1):125-32. PubMed ID: 18277618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro / in vivo evaluation of NCDS-micro-fabricated biodegradable implant.
    Park CW; Rhee YS; Park SH; Danh SD; Ahn SH; Chi SC; Park ES
    Arch Pharm Res; 2010 Mar; 33(3):427-32. PubMed ID: 20361308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual drug delivery of 5-fluorouracil (5-FU) and methotrexate (MTX) through random copolymeric nanomicelles of PLGA and polyethylenimine demonstrating enhanced cell uptake and cytotoxicity.
    Ashwanikumar N; Kumar NA; Nair SA; Kumar GSV
    Colloids Surf B Biointerfaces; 2014 Oct; 122():520-528. PubMed ID: 25108479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy.
    Lin Y; Li Y; Ooi CP
    J Mater Sci Mater Med; 2012 Oct; 23(10):2453-60. PubMed ID: 22843166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D,L-lactide-co-glycolide) discs and polymer degradation.
    Kim JM; Seo KS; Jeong YK; Hai BL; Kim YS; Khang G
    J Biomater Sci Polym Ed; 2005; 16(8):991-1007. PubMed ID: 16128233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low temperature formation of calcium-deficient hydroxyapatite-PLA/PLGA composites.
    Durucan C; Brown PW
    J Biomed Mater Res; 2000 Sep; 51(4):717-25. PubMed ID: 10880121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged release from PLGA/HAp scaffolds containing drug-loaded PLGA/gelatin composite microspheres.
    Tang G; Zhang H; Zhao Y; Li X; Yuan X; Wang M
    J Mater Sci Mater Med; 2012 Feb; 23(2):419-29. PubMed ID: 22095448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
    Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
    Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of soluble, salt-loaded, degradable PLGA films and their release of tetracycline.
    Webber WL; Lago F; Thanos C; Mathiowitz E
    J Biomed Mater Res; 1998 Jul; 41(1):18-29. PubMed ID: 9641620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable microparticulates of beta-estradiol: preparation and in vitro characterization.
    Zaghloul AA; Mustafa F; Siddiqu A; Khan M
    Drug Dev Ind Pharm; 2005 Sep; 31(8):803-11. PubMed ID: 16221615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aligned PLGA/HA nanofibrous nanocomposite scaffolds for bone tissue engineering.
    Jose MV; Thomas V; Johnson KT; Dean DR; Nyairo E
    Acta Biomater; 2009 Jan; 5(1):305-15. PubMed ID: 18778977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration.
    Widmer MS; Gupta PK; Lu L; Meszlenyi RK; Evans GR; Brandt K; Savel T; Gurlek A; Patrick CW; Mikos AG
    Biomaterials; 1998 Nov; 19(21):1945-55. PubMed ID: 9863528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel porous hydroxyapatite prepared by combining H2O2 foaming with PU sponge and modified with PLGA and bioactive glass.
    Huang X; Miao X
    J Biomater Appl; 2007 Apr; 21(4):351-74. PubMed ID: 16543281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical and mechanical properties of freeze cast hydroxyapatite-gelatin scaffolds with dexamethasone loaded PLGA microspheres for hard tissue engineering applications.
    Ghorbani F; Nojehdehian H; Zamanian A
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():208-20. PubMed ID: 27612706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and physicochemical characterization of T-OA PLGA microspheres.
    Fu J; Dong XX; Zeng ZP; Yin XB; Li FW; Ni J
    Chin J Nat Med; 2017 Dec; 15(12):912-916. PubMed ID: 29329648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fabrication of nano-hydroxyapatite on PLGA and PLGA/collagen nanofibrous composite scaffolds and their effects in osteoblastic behavior for bone tissue engineering.
    Ngiam M; Liao S; Patil AJ; Cheng Z; Chan CK; Ramakrishna S
    Bone; 2009 Jul; 45(1):4-16. PubMed ID: 19358900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inorganic apatite nanomaterial: Modified surface phenomena and its role in developing collagen based polymeric bio-composite (Coll-PLGA/HAp) for biological applications.
    Selvaraju S; Ramalingam S; Rao JR
    Colloids Surf B Biointerfaces; 2018 Dec; 172():734-742. PubMed ID: 30248644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
    Nie H; Wang CH
    J Control Release; 2007 Jul; 120(1-2):111-21. PubMed ID: 17512077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.